These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 12966593)

  • 21. Monitoring of immune activation using biochemical changes in a porcine model of cardiac arrest.
    Amann A; Widner B; Rieder J; Antretter H; Hoffmann G; Mayr V; Strohmenger HU; Fuchs D
    Mediators Inflamm; 2001 Dec; 10(6):343-6. PubMed ID: 11817676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation.
    Weiss G; Schroecksnadel K; Mattle V; Winkler C; Konwalinka G; Fuchs D
    Eur J Haematol; 2004 Feb; 72(2):130-4. PubMed ID: 14962250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indoleamine 2,3-dioxygenase in lung allograft tolerance.
    Meloni F; Giuliano S; Solari N; Draghi P; Miserere S; Bardoni AM; Salvini R; Bini F; Fietta AM
    J Heart Lung Transplant; 2009 Nov; 28(11):1185-92. PubMed ID: 19783182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia.
    Suzuki Y; Suda T; Yokomura K; Suzuki M; Fujie M; Furuhashi K; Hahimoto D; Enomto N; Fujisawa T; Nakamura Y; Inui N; Nakano Y; Nakamura H; Chida K
    J Infect; 2011 Sep; 63(3):215-22. PubMed ID: 21784100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased tryptophan degradation in patients with bronchus carcinoma.
    Engin AB; Ozkan Y; Fuchs D; Yardim-Akaydin S
    Eur J Cancer Care (Engl); 2010 Nov; 19(6):803-8. PubMed ID: 19702697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tryptophan metabolism in chronic inflammatory lung disease.
    Meyer KC; Arend RA; Kalayoglu MV; Rosenthal NS; Byrne GI; Brown RR
    J Lab Clin Med; 1995 Dec; 126(6):530-40. PubMed ID: 7490512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased plasma tryptophan in pregnancy.
    Schröcksnadel H; Baier-Bitterlich G; Dapunt O; Wachter H; Fuchs D
    Obstet Gynecol; 1996 Jul; 88(1):47-50. PubMed ID: 8684760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
    Widner B; Leblhuber F; Fuchs D
    J Neural Transm (Vienna); 2002 Feb; 109(2):181-9. PubMed ID: 12075858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells.
    Schroecksnadel S; Sucher R; Kurz K; Fuchs D; Brandacher G
    Transpl Immunol; 2011 Sep; 25(2-3):119-23. PubMed ID: 21742032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring tryptophan metabolism in chronic immune activation.
    Schröcksnadel K; Wirleitner B; Winkler C; Fuchs D
    Clin Chim Acta; 2006 Feb; 364(1-2):82-90. PubMed ID: 16139256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tryptophan degradation and immune activation in Alzheimer's disease.
    Widner B; Leblhuber F; Walli J; Tilz GP; Demel U; Fuchs D
    J Neural Transm (Vienna); 2000; 107(3):343-53. PubMed ID: 10821443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tryptophan degradation during and after gestation.
    Schröcksnadel K; Widner B; Bergant A; Neurauter G; Schröcksnadel H; Fuchs D
    Adv Exp Med Biol; 2003; 527():77-83. PubMed ID: 15206718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection.
    Bellmann-Weiler R; Schroecksnadel K; Holzer C; Larcher C; Fuchs D; Weiss G
    J Affect Disord; 2008 May; 108(1-2):171-6. PubMed ID: 17945348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
    López AS; Alegre E; LeMaoult J; Carosella E; González A
    Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal study of tryptophan degradation during and after pregnancy.
    Schröcksnadel K; Widner B; Bergant A; Neurauter G; Schennach H; Schröcksnadel H; Fuchs D
    Life Sci; 2003 Jan; 72(7):785-93. PubMed ID: 12479977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life and immune activation in patients with HIV-infection.
    Schroecksnadel K; Sarcletti M; Winkler C; Mumelter B; Weiss G; Fuchs D; Kemmler G; Zangerle R
    Brain Behav Immun; 2008 Aug; 22(6):881-9. PubMed ID: 18261883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.
    Brandacher G; Cakar F; Winkler C; Schneeberger S; Obrist P; Bösmüller C; Werner-Felmayer G; Werner ER; Bonatti H; Margreiter R; Fuchs D
    Kidney Int; 2007 Jan; 71(1):60-7. PubMed ID: 17136028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced degradation of tryptophan in patients on hemodialysis.
    Koenig P; Nagl C; Neurauter G; Schennach H; Brandacher G; Fuchs D
    Clin Nephrol; 2010 Dec; 74(6):465-70. PubMed ID: 21084050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients.
    Kato A; Suzuki Y; Suda T; Suzuki M; Fujie M; Takita T; Furuhashi M; Maruyama Y; Chida K; Hishida A
    Hemodial Int; 2010 Oct; 14(4):418-24. PubMed ID: 20673309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.